• Latest Posts

Affibody and Chiesi Group to develop treatments for respiratory diseases

Affibody signs €20 million loan agreement

Rallybio announces positive phase 1 results for drug treating PNH and gMG

Swedish Biotech’s Psoriasis Drug Beats Placebo in Phase II

Affibody Signs €208M Deal To Market Autoimmune Drug in China

Expert Advice 5 Nov 2019

How Sweden’s Intellectual Property Law Boosts Biotech Innovation